Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.800
+0.050 (1.05%)
At close: Aug 14, 2026, 4:00 PM EDT
4.752
-0.048 (-1.00%)
After-hours: Aug 14, 2026, 7:35 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $512.02 million as of August 14, 2026. Its market cap has increased by 2,609.08% in one year.
Market Cap
512.02M
Enterprise Value
294.28M
1-Year Change
2,609.08%
Ranking
Category
Stock Price
$4.80
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $512.02M, an increase of 804.62%. That is a compound annual growth rate of 22.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 512.00M | 44.55% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 544.94M |
| Contineum Therapeutics | 533.84M |
| Zura Bio | 533.77M |
| Evommune | 531.68M |
| Adlai Nortye | 530.00M |
| C4 Therapeutics | 521.63M |
| Kyverna Therapeutics | 505.26M |
| Entera Bio | 500.38M |